Medindia

X

Boehringer Ingelheim Receives Top Honor as World's Most Respected Biopharmaceutical Employer in Science 2007 Top Employers Survey

Saturday, October 13, 2007 General News J E 4
Advertisement
RIDGEFIELD, Conn., Oct. 12 Boehringer Ingelheim todayannounced that the company has been awarded top honors by Science as theworld's most respected biopharmaceutical employer. Science's annual survey ofmore than 470 Top Employers polls employees in the biotechnology,biopharmaceutical, pharmaceutical, and related industries. Respondents to theweb-based survey are asked to rate companies based on 23 drivingcharacteristics, including corporate image, leadership and direction,financial strength, company culture, work/life balance, compensation, andbenefits, as well as being easily adaptable to change and having a thrivingresearch-driven environment.

"We are very pleased to be recognized as a global leader in thepharmaceutical industry by Science," said J. Martin Carroll, president andchief executive officer of Boehringer Ingelheim Corporation. "It isespecially gratifying to receive this honor knowing it is a measurement ofcorporate reputation among both our employees and the employees of ourcompetitors. This international recognition truly signifies that BoehringerIngelheim is an Employer of Choice in the United States and around the world."

Over the past few years that Science has carried out this survey,Boehringer Ingelheim has climbed up in ranking, from 8th place in 2005 tosecond place last year. This year, Boehringer Ingelheim reached the topranking, recognizing the company's strong commitment to innovative thinkingthroughout the product pipeline, from the laboratory to the marketplace, whileestablishing an excellent working environment.

Like Science's 2006 ranking of biopharma employers, the 2007 survey soughtto identify the companies with the best reputations as employers, based on3,157 survey responses from readers of Science and other respondents inindustry. Twenty-nine percent of respondents came from outside of the UnitedStates, primarily Western Europe, and more than 90 percent worked in privateindustry.

The rankings, determined from a study conducted by an independent researchfirm commissioned by the business office of the journal, will appear in aspecial business supplement of the 12 October 2007 issue. Survey responseswere analyzed by Senn-Delaney Culture

Diagnostics & Measurement, which used a mathematical process to assign aunique score to rate the companies' employer reputation. Each companyreceived a ranking, for example, on the basis of whether it treats itsemployees with respect, whether its work-culture values align with employees'personal values, and other factors.

For the complete business office supplement with individual companyrankings, visithttp://sciencecareers.sciencemag.org/career_development/previous_issues/articles/2007_10_12/science_opms_r0700041.

About the American Association for the Advancement of Science (AAAS)

The American Association for the Advancement of Science (AAAS) is theworld's largest general scientific society, and publisher of the journal,Science (www.sciencemag.org). AAAS was founded in 1848, and includes some 262affiliated societies and academies of science, serving 10 million individuals.Science has the largest paid circulation of any peer-reviewed general sciencejournal in the world, with an estimated total readership of one million. Thenon-profit AAAS (www.aaas.org) is open to all and fulfills its mission to"advance science and serve society" through initiatives in science policy,international programs, science education, and more.

About Boehringer Ingelheim

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, isthe largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield,CT) and a member of the Boehringer Ingelheim group of companies. TheBoehringer Ingelheim group is one of the world's 20 leading pharmaceuticalcompanies. Headquartered in Ingelheim, Germany, it operates globally with 137aff
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Daiichi Sankyo and Forest Laboratories Finalize Co...
S
Sunrise Settles Litigation Regarding Its 2007 Annu...